Клініка RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)
Терапія стовбуровими клітинами при ДЦП у Республіці Корея зазвичай коштує від $18,500 до $35,000. Ціна залежить від методу введення, джерела клітин та розташування клініки. Більшість програм охоплюють первинні консультації, неврологічні обстеження та професійне введення стовбурових клітин.
Експертна думка Bookimed: Вибір спеціалізованих центрів часто вигідніший, ніж звичайних лікарень. RE:YOUTH у Чхонані — єдина корейська установа, що спеціалізується на артеріальній клітинній терапії. Метод забезпечує доставку клітин безпосередньо до органів, а не системний розподіл. Команда залучає фахівців Університету Йонсей та Медичного центру Асан. Ці експерти щороку лікують понад 1 000 пацієнтів. Великий досвід роботи сприяє вдосконаленню протоколів неврологічної допомоги.
Чому обрати Республіку Корея для терапії стовбуровими клітинами при церебральному паралічі?
Отримайте доступ до передових рішень терапії стовбуровими клітинами для церебрального паралічу в надійних клініках .
| Південна Корея | Туреччина | Україна | |
| Терапія стовбуровими клітинами при ДЦП | від $18,500 | від $15,000 | від $5,000 |
Ви не сплачуєте за послуги Bookimed. Ціни на терапію стовбуровими клітинами при дцп відповідають прайс-листу клініки. Оплата безпосередньо в клініці. Доступна оплата частинами.
Bookimed піклується про вашу безпеку. Ми співпрацюємо лише з медичними закладами, які дотримуються високих міжнародних стандартів у проведенні терапії стовбуровими клітинами при ДЦП та мають необхідні ліцензії для обслуговування пацієнтів з різних країн.
Bookimed надає безкоштовну експертну підтримку. Особистий лікар-координатор супроводжує вас до, під час та після процедур, вирішуючи будь-які питання. Ви ніколи не залишитеся наодинці під час процедури Терапія стовбуровими клітинами при ДЦП в іншій країні.
День 1
день 2
день 3
День 4
День 5
1-2 тиждень
3-4 тиждень
5-6 тиждень
Будь ласка, зверніть увагу, що випадок кожного пацієнта унікальний, і часові рамки можуть відрізнятися залежно від індивідуальної реакції на лікування.
Терапія стовбуровими клітинами при церебральному паралічі використовує регенеративну медицину для відновлення пошкоджених клітин мозку та покращення моторних функцій.
The primary goal of stem-cell therapy for cerebral palsy in South Korea is to repair neurological damage and enhance motor function by addressing root causes. Specialized clinics use regenerative cells to target damaged brain tissue, suppress neuro-inflammation, and promote the growth of new neural pathways.
Bookimed Expert Insight: While standard treatments use IV drips, some Korean clinics like RE:YOUTH (YONSEI BH Arterial Stemcell Clinic) specialize in 100% arterial delivery. This method targets cells directly to the brain, which may explain why institutions like CHA Bundang see significant motor gains. With over 1,000 patients treated annually at top centers, this high volume supports refined, safer delivery protocols.
Patient Consensus: Many families report that while changes are incremental rather than transformative, children often show measurable gains in mobility. It is essential to combine these sessions with intensive physical therapy to maximize the benefits of improved neuroplasticity.
South Korea primarily uses umbilical cord blood and mesenchymal stem cells (MSCs) from donor umbilical cords or adipose tissue to treat cerebral palsy. These therapies focus on neuroprotection and regeneration, often involving advanced delivery methods like arterial injections to target specialized brain tissues directly.
Bookimed Expert Insight: While standard IV therapy is common globally, South Korean clinics like RE:YOUTH utilize a unique arterial delivery method. This technique aims to bypass traditional circulation filters. This ensures a higher concentration of stem cells reaches the brain safely. This innovation likely contributes to South Korea's high global ranking for complex neurological care.
Patient Consensus: Families often observe better hand function and reduced spasticity after multiple infusions. Many suggest completing a pre-treatment MRI and pairing therapy with daily physiotherapy for the best results.
Stem cells for pediatric cerebral palsy in the Republic of Korea are delivered via intravenous (IV) infusion, intrathecal (spinal) injection, or specialized arterial catheterization. These methods bypass the blood-brain barrier to promote neural repair, often requiring multiple sessions over 3 to 7 days.
Bookimed Expert Insight: While IV and spinal routes are standard, the arterial catheter method at clinics like RE:YOUTH in Cheonan offers a unique advantage for brain uptake. Our data shows these specialized Korean protocols often include 2 to 4 delivery sessions per treatment cycle to maximize cellular integration. This intensive approach is typically paired with immediate neurological rehabilitation to enhance motor gains.
Patient Consensus: Families often report seeing improvements in spasticity within 4 to 8 weeks. Most suggest requesting a third-party cell-viability report and starting intensive physiotherapy immediately after the sessions to see the best results.
Clinical improvements after stem-cell therapy in the Republic of Korea include reduced spasticity, enhanced motor function, and improved tissue regeneration. Patients often experience better mobility and significant pain reduction. Specialist clinics in Seoul and Cheonan use targeted arterial injections to deliver cells directly to damaged brain or joint tissues.
Bookimed Expert Insight: Bookimed data shows that Republic of Korea clinics specialize in high-precision delivery methods. While standard IV therapy is common globally, Korean centers like RE:YOUTH focus on arterial injections. This technique targets the brain directly to improve outcomes for cerebral palsy. This advanced approach helps explain the high patient volume of 1,000 people annually at specialized facilities.
Patient Consensus: Functional gains in walking and strength are most noticeable when combining stem cells with intensive physical therapy. Many families find that while physical mobility improves, cognitive or speech changes are less frequent and harder to measure.
Children under age 5 benefit most from stem-cell therapy for cerebral palsy due to peak neuroplasticity. Younger brains adapt faster to regenerative signals, while gross motor development naturally peaks between ages 3 and 6, allowing for more visible functional gains during this critical window.
Bookimed Expert Insight: Korean clinics like RE:YOUTH specialize in arterial delivery rather than standard IV drips. Data shows this targeted method bypasses the lung-filtering effect, delivering cells directly to the brain. This is crucial for older children whose lower natural plasticity requires a higher concentration of cells to trigger measurable motor improvements.
Patient Consensus: Parents of children aged 2–8 report the most dramatic improvements in walking ability. While teens and adults see less motor gain, they frequently experience significant relief from muscle spasticity and chronic pain.
South Korean safety for stem cell therapy is governed by the Act on Advanced Regenerative Medicine and Advanced Biological Products (ARMAB). Facilities must be Ministry of Food and Drug Safety (MFDS) designated institutions. Strict Good Manufacturing Practice (GMP) standards ensure cell sterility, while mandatory long-term tracking monitors patient recovery and adverse effects.
Bookimed Expert Insight: While many local centers focus on standard IV infusions, top-tier clinics like RE:YOUTH utilize arterial catheter delivery. This specialized technique ensures 100% organ uptake compared to systemic IV methods. This high-precision approach is often why specialized Korean centers serve over 1,000 patients annually with reported success.
Patient Consensus: Patients emphasize verifying MFDS approval for specific products rather than trusting general clinic claims. Experienced families recommend independent neurologists to document baseline motor function before and after expensive treatment cycles.
South Korean stem cell packages for cerebral palsy typically include advanced administration like arterial or intrathecal delivery, diagnostics, and logistics. Standard bundles provide cord-derived mesenchymal cells, specialized neuro-rehabilitation, airport transfers, and translation services. Most facilities, such as RE:YOUTH, operate under KOIHA quality standards for international patient safety.
Bookimed Expert Insight: While standard IV therapy is common, South Korean clinics like RE:YOUTH utilize an arterial delivery method. Data indicates this technique targets organs directly with higher cell concentrations. If choosing a package, prioritize those including hyperbaric oxygen therapy, as this often drives the most visible motor gains.
Patient Consensus: Many families found the daily physical therapy and hyperbaric sessions more impactful than the injections alone. They advise requesting a full itemized breakdown to ensure rehabilitation hours are clearly defined before arrival.